Health & Environmental Research Online (HERO)


Print Feedback Export to File
4825616 
Journal Article 
Perfluoroalkylated substances (PFAS) affect neither estrogen and androgen receptor activity nor steroidogenesis in human cells in vitro 
Behr, AC; Lichtenstein, D; Braeuning, A; Lampen, A; Buhrke, T 
2018 
Yes 
Toxicology Letters
ISSN: 0378-4274
EISSN: 1879-3169 
291 
51-60 
English 
The perfluoroalkylated substances (PFAS) perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) are used for the fabrication of water- and dirt-repellent surfaces. The use of PFOS and PFOA was restricted due to their reprotoxic properties and their environmental persistence. Therefore, industry switches to alternative PFAS, however, in contrast to PFOA and PFOS only few toxicological data are available for their substitutes. The molecular mechanism(s) underlying reproductive toxicity of PFOA and PFOS are largely unknown. Here, the endocrine properties of PFOA, PFOS, and of six substitutes including perfluorohexanesulfonic acid (PFHxS), perfluorobutanesulfonic acid (PFBS), perfluorohexanoic acid (PFHxA), perfluorobutanoic acid (PFBA), ammonium perfluoro(2-methyl-3-oxahexanoate) (PMOH), and 3H-perfluoro-3-[(3-methoxypropoxy) propanoic acid] (PMPP) were examined in vitro by using human cell lines such as MCF-7, H295R, LNCaP and MDA-kb2. PFOA, PFOS and PMOH enhanced 17β-estradiol-stimulated estrogen receptor β activity, and PFOS, PMOH, PFHxA and PFBA enhanced dihydrotestosterone-stimulated androgen receptor activity. In the H295R steroidogenesis assay, PFOA and PFOS slightly enhanced estrone secretion, and progesterone secretion was marginally increased by PFOA. All these effects were only observed at concentrations above 10 μM, and none of the PFAS displayed any effect on any of the molecular endocrine endpoints at concentrations of 10 μM or below. Thus, as the blood serum concentrations of the different PFAS in the general Western population are in the range of 10 nM or below, the results suggest that PFAS might not exert endocrine effects in humans at exposure-relevant concentrations according to the molecular endpoints examined in this study. 
Perfluoroalkylated substances (PFAS); PFOA; PFOS; Steroidogenesis; Androgen receptor; Estrogen receptor 
PFAS
• GenX Chemicals (CASRN 13252-13-6 and CASRN 62037-80-3)
     LitSearch - GenX: July 2017 - Feb 2019
          PubMed
          WoS
     LitSearch GenX Ammonium Salt: Feb 2018 - Feb 2019
          WoS
• PFBA
     Literature Search Update 5/2019
          PubMed
          WOS
• PFBS
     Search Update 5/2019
          PubMed
          WOS
• PFHxA
     LitSearch: Feb 2018 - May 2019
          PubMed
          ToxNet
          WoS
• PFHxS
     LitSearch: Feb 2018 - May 2019
          PubMed
          ToxNet
          WoS
• PFNA
     PFNA May 2019 Update
          Toxnet
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search Update (2013-2019)
          PubMed
          WOS